Detalls del projecte
Description
Funded by the Marie Skłodowska-Curie Actions programme, the TOLERATE project will provide training in the development of innovative strategies for autoimmune disease treatment to bring novel therapeutic agents to the market. The objective is to introduce innovative tolerogenic therapies for the treatment of autoimmune diseases using cell therapy, nanotechnology and protein-engineered tolerogenic vaccines to re-establish immune tolerance. The TOLERATE platform will provide eight doctoral candidates with unique interdisciplinary clinical skills together with additional training in ethical, regulatory and legal aspects in the development of therapeutics and diagnostics for autoimmune diseases.
| Acrònim | TOLERATE |
|---|---|
| Estatus | Actiu |
| Data efectiva d'inici i finalització | 1/10/22 → 30/09/26 |
Socis col·laboradors
- Universitat Autònoma de Barcelona (UAB)
- Katholieke Universiteit Leuven (KU Leuven) (Coordinador) (guia)
- Stichting Sanquin Bloedvoorziening (Soci projecte)
- Semmelweis University (Soci projecte)
- Assistance publique - Hôpitaux de Paris (APHP) (Soci projecte)
- Royal College of Surgeons in Ireland (Soci projecte)
- Helmholtz-Zentrum Dresden-Rossendorf (Soci projecte)
- Anicells (Soci projecte)
Fingerprint
Explora els temes de recerca tractats en aquest projecte. Les etiquetes es generen en funció dels ajuts rebuts. Juntes formen un fingerprint únic.